Takeda; Tomoko

Patent Applications and Registrations

Patent applications and USPTO patent grants for Takeda; Tomoko.The latest application filed is for "therapeutic agent for inflammatory bowel disease and tnf-alpha production inhibitor".

Company Profile

1.9.12

Takeda; Tomoko - Kawasaki-shi JP
Takeda; Tomoko - Kawasaki JP
Takeda; Tomoko - Gifu-shi JP
Takeda; Tomoko - Kanagawa JP

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Therapeutic Agent For Inflammatory Bowel Disease And Tnf-alpha Production Inhibitor App 20120329846 - Matsumoto; Hideki ; et al.	2012-12-27
Diarylalkene derivatives and novel diarylalkane derivatives Grant 8,278,329 - Yamamoto , et al. October 2, 2	2012-10-02
Therapeutic agent for inflammatory bowel disease and TNF-.alpha. production inhibitor Grant 8,168,669 - Matsumoto , et al. May 1, 2	2012-05-01
Efficient Method For Establishing Induced Pluripotent Stem Cells App 20110201110 - Tezuka; Kenichi ; et al.	2011-08-18
Pharmaceutical composition containing gabapentin or pregabalin and N-type calcium channel antagonist Grant 7,713,957 - Iwayama , et al. May 11, 2	2010-05-11
Therapeutic Agent For Inflammatory Bowel Disease And Tnf-alpha Production Inhibitor App 20100076044 - MATSUMOTO; Hideki ; et al.	2010-03-25
Pyridine compounds useful as N-type calcium channel antagonists Grant 7,494,989 - Ohno , et al. February 24, 2	2009-02-24
Diarylalkene derivatives and novel diarylalkane derivatives Grant 7,462,630 - Yamamoto , et al. December 9, 2	2008-12-09
Therapeutic Agent For Inflammatory Bowel Disease And Tnf-alfa Production Inhibitor App 20080108684 - MATSUMOTO; HIDEKI ; et al.	2008-05-08
New Pyrimidine Derivatives And New Pyridine Derivatives App 20080070903 - OHNO; Seiji ; et al.	2008-03-20
Novel Diarylalkene Derivatives And Novel Diarylalkane Derivatives App 20080058311 - YAMAMOTO; Takashi ; et al.	2008-03-06
Pyrimidine compounds useful as N-type calcium channel antagonists Grant 7,288,544 - Ohno , et al. October 30, 2	2007-10-30
Dihydropyridine derivatives Grant 7,247,645 - Nakanishi , et al. July 24, 2	2007-07-24
Dihydropyrimidine compounds and compositions containing the same Grant 6,855,716 - Ohno , et al. February 15, 2	2005-02-15
Pharmaceutical composition containing gabapentin or pregabalin and N-type calcium channel antagonist App 20050009814 - Iwayama, Satoshi ; et al.	2005-01-13
Novel diarylalkene derivatives and novel diarylalkane derivatives App 20040167118 - Yamamoto, Takashi ; et al.	2004-08-26
Pyrimidine derivatives and new pyridine derivatives App 20040009991 - Ohno, Seiji ; et al.	2004-01-15
Dihydropyridine derivatives Grant 6,610,717 - Nakajo , et al. August 26, 2	2003-08-26
New dihydropyridine derivatives App 20020193605 - Nakajo, Akira ; et al.	2002-12-19
Dihydropyridine derivatives App 20020147222 - Nakanishi, Chika ; et al.	2002-10-10
Dihydropyrimidine compounds and compositions containing the same App 20020143023 - Ohno, Seiji ; et al.	2002-10-03

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.